ROR1 and cancer: Strictinin had minimal impact on RWPE-1 cells (normal prostatic epithelium) and moderate phenotypic anti-cancerous effects on DU145 cells (ARneg-AI cancer), which is most likely due to the minimal and moderate expression of ROR1 found in RWPE-1 cells and DU145 cells, respectively [30].